One stock in the biotechnology and drugs complex that's already starting to enter breakout territory is Cambrex (CBM), a life sciences company that provides essential products and services to accelerate drug discovery, development and manufacturing processes for human therapeutics. This stock has been blazing a path to the upside so far in 2012, with shares up over 85%.
If you take a look at the chart for Cambrex, you'll notice that this stock has been trending sideways for the last two months, with shares moving between $11.60 on the downside and $13.77 on the upside. As CBM has trended sideways, the stock has managed to hold above its 50-day moving average. A move outside of that sideways range will likely setup the next major trend for CBM.Traders should now look for long-biased trades in CBM once it manages to break out above some near-term overhead resistance at $13.77 a share with high volume. Look for a sustained move or close above $13.77 with volume that hits near or above its three-month average action of 261,283 shares. If that breakout triggers soon, then CBM will have a great chance of re-testing or possibly taking out its next major overhead resistance at around $24 a share. Traders can look to buy CBM off any weakness to anticipate that breakout, and simply use a stop that sits right below its 50-day moving average of $12.29 a share. Take-Two Interactive Software Another stock in the that's setting up for a near-term breakout trade is Take-Two Interactive Software (TTWO), a developer, marketer and publisher of interactive entertainment for consumers around the globe. This stock is off to a weak start in 2012, with shares down by around 18%. >>5 Toxic Tech Stocks to Sell Now If you take a look at the chart for Take-Two Interactive Software, you'll see that this stock has also been trending sideways for the last month and change, with shares moving between $9.86 on the downside and $11.36 on the upside. During that timeframe, shares of TTWO have been able to hold its trend above its 50-day moving average. A move outside of that range for TTWO will likely setup the next major trend for the stock.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV